Borel-Rinkes IH - Search Results

1

Synergistic killing of colorectal cancer cells by oxaliplatin and ABT-737.

Raats DA, de Bruijn MT, Steller EJ, Emmink BL, Borel-Rinkes IH, Kranenburg O. Raats DA, et al. Cell Oncol (Dordr). 2011 Aug;34(4):307-13. doi: 10.1007/s13402-011-0026-8. Epub 2011 Apr 6. Cell Oncol (Dordr). 2011. PMID: 21468686

2

Validation of bioluminescence imaging of colorectal liver metastases in the mouse.

Smakman N, Martens A, Kranenburg O, Borel Rinkes IH. Smakman N, et al. J Surg Res. 2004 Dec;122(2):225-30. doi: 10.1016/j.jss.2004.05.021. J Surg Res. 2004. PMID: 15555622

3

Cyclooxygenase-2 is a target of KRASD12, which facilitates the outgrowth of murine C26 colorectal liver metastases.

Smakman N, Kranenburg O, Vogten JM, Bloemendaal AL, van Diest P, Borel Rinkes IH. Smakman N, et al. Clin Cancer Res. 2005 Jan 1;11(1):41-8. Clin Cancer Res. 2005. PMID: 15671526

4

Early endostatin treatment inhibits metastatic seeding of murine colorectal cancer cells in the liver and their adhesion to endothelial cells.

te Velde EA, Reijerkerk A, Brandsma D, Vogten JM, Wu Y, Kranenburg O, Voest EE, Gebbink M, Borel Rinkes IH. te Velde EA, et al. Br J Cancer. 2005 Feb 28;92(4):729-35. doi: 10.1038/sj.bjc.6602385. Br J Cancer. 2005. PMID: 15700042 Free PMC article.

5

Mouse models of colorectal cancer and liver metastases.

Heijstek MW, Kranenburg O, Borel Rinkes IH. Heijstek MW, et al. Dig Surg. 2005;22(1-2):16-25. doi: 10.1159/000085342. Epub 2005 Apr 14. Dig Surg. 2005. PMID: 15838167 Free article. Review.

6

Ischemia/reperfusion accelerates the outgrowth of hepatic micrometastases in a highly standardized murine model.

van der Bilt JD, Kranenburg O, Nijkamp MW, Smakman N, Veenendaal LM, Te Velde EA, Voest EE, van Diest PJ, Borel Rinkes IH. van der Bilt JD, et al. Hepatology. 2005 Jul;42(1):165-75. doi: 10.1002/hep.20739. Hepatology. 2005. PMID: 15962318

7

Dual effect of Kras(D12) knockdown on tumorigenesis: increased immune-mediated tumor clearance and abrogation of tumor malignancy.

Smakman N, Veenendaal LM, van Diest P, Bos R, Offringa R, Borel Rinkes IH, Kranenburg O. Smakman N, et al. Oncogene. 2005 Dec 15;24(56):8338-42. doi: 10.1038/sj.onc.1208995. Oncogene. 2005. PMID: 16091732

8

NS-398, a selective cyclooxygenase-2 inhibitor, reduces experimental bladder carcinoma outgrowth by inhibiting tumor cell proliferation.

Smakman N, Schaap N, Snijckers CM, Borel Rinkes IH, Kranenburg O. Smakman N, et al. Urology. 2005 Aug;66(2):434-40. doi: 10.1016/j.urology.2005.02.024. Urology. 2005. PMID: 16098373

9

Control of colorectal metastasis formation by K-Ras.

Smakman N, Borel Rinkes IH, Voest EE, Kranenburg O. Smakman N, et al. Biochim Biophys Acta. 2005 Nov 25;1756(2):103-14. doi: 10.1016/j.bbcan.2005.07.001. Epub 2005 Aug 10. Biochim Biophys Acta. 2005. PMID: 16098678 Review.

10

Sensitization to apoptosis underlies KrasD12-dependent oncolysis of murine C26 colorectal carcinoma cells by reovirus T3D.

Smakman N, van den Wollenberg DJ, Borel Rinkes IH, Hoeben RC, Kranenburg O. Smakman N, et al. J Virol. 2005 Dec;79(23):14981-5. doi: 10.1128/JVI.79.23.14981-14985.2005. J Virol. 2005. PMID: 16282499 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

360 results

Search Page

Filters